Magsayo, Marjie D.

HRN: 11-72-87  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2026
CEFUROXIME 750MG (VIAL)
06/11/2026
06/17/2026
IV
750mg
Q8
Uti
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: